glp 1 agonist review GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes GLP1 agonists: current and future

However, these symptoms can negatively affect treatment adherence, quality of life, and discontinuation rates, thereby impacting long-term treatment success

doi: 10.3233/JAD-191068 9 MiaoYGuoDLiWZhongY

HF, heart failure

Effect of glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors among obese/overweight individuals treated with antipsychotic drug classes: an updated systematic review and meta-analysis of randomized controlled trials

Psychiatry, 28 (1): 217229

Of these receptor subtypes, Y1R and Y2R are particularly involved in modulating bone mass, but they do so through different mechanisms and at different sites